Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.16/2233
Título: Predictive clinical model of tumor response after chemoradiation in rectal cancer
Autor: Santos, M.
Silva, C.
Rocha, A.
Nogueira, C.
Castro-Poças, F.
Araujo, A.
Matos, E.
Pereira, C.
Medeiros, R.
Lopes, C.
Palavras-chave: molecular marker
neoadjuvant chemoradiation
neutrophil lymphocyte ratio
prediction
rectal cancer
Data: 28-Jul-2017
Editora: Impact Journals
Citação: Oncotarget. 2017 Jul 28;8(35):58133-58151
Resumo: Survival improvement in rectal cancer treated with neoadjuvant chemoradiotherapy (nCRT) is achieved only if pathological response occurs. Mandard tumor regression grade (TRG) proved to be a valid system to measure nCRT response. The ability to predict tumor response before treatment may significantly have impact the selection of patients for nCRT in rectal cancer. The aim is to identify potential predictive pretreatment factors for Mandard response and build a clinical predictive model design. 167 patients with locally advanced rectal cancer were treated with nCRT and curative surgery. Blood cell counts in peripheral blood were analyzed. Pretreatment biopsies expression of cyclin D1, epidermal growth factor receptor (EGFR), vascular endothelial growth factor (VEGF) and protein 21 were assessed. A total of 61 single nucleotide polymorphisms were characterized using the Sequenom platform through multiplex amplification followed by mass-spectometric product separation. Surgical specimens were classified according to Mandard TRG. The patients were divided as: "good responders" (Mandard TRG1-2) and "poor responders" (Mandard TGR3-5). We examined predictive factors for Mandard response and performed statistical analysis. In univariate analysis, distance from anal verge, neutrophil lymphocyte ratio (NLR), cyclin D1, VEGF, EGFR, protein 21 and rs1810871 interleukin 10 (IL10) gene polymorphism are the pretreatment variables with predictive value for Mandard response. In multivariable analysis, NLR, cyclin D1, protein 21 and rs1800871 in IL10 gene maintain predictive value, allowing a clinical model design.
Peer review: yes
URI: http://hdl.handle.net/10400.16/2233
DOI: 10.18632/oncotarget.19651
ISSN: 1949-2553
Versão do Editor: http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=view&path[]=19651&pubmed-linkout=1
Aparece nas colecções:SAP - Artigos publicados em revistas indexadas na Medline
SOnc - Artigos publicados em revistas indexadas na Medline
SG - Artigos publicados em revistas indexadas na Medline
Cir.1 - Artigos publicados em revistas indexadas na Medline

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Predictive clinical model of tumor response.pdf1,85 MBAdobe PDFVer/Abrir


FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.